Kidron Nadav
- SEC CIK
- 0001351779
No open-market purchases or sales filed in the past year.
Current role at each company
- ORMP Oramed Pharmaceuticals Inc.President and CEOas of Sep 25, 2026
- NNDM Nano Dimension Ltd.Directoras of Aug 25, 2026
- LFWD Lifeward Ltd.Directoras of Mar 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kidron Nadav as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ORMP Oramed Pharmaceuticals Inc.
President and CEO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2023 (view filing) | Mar 16 | Same day | Kidron NadavPresident and CEO | PPurchase | +26.0K | $2.04 | +$53.0K | +26.0%126.0K after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Kidron NadavPresident and CEO | PPurchase | +100.0K | $2.01 | +$201.0K | New position100.0K after | |
| Dec 7, 2021 (view filing) | Aug 9 | 120 days | Kidron NadavPresident and CEO | SSale | −220.0K | $20.11 | −$4.42M | −23.0%738.2K after | Amended |